Phytecs explores innovative clinical and preclinical endocannabinoid interventions that expand the options available to physicians, healthcare professionals and patients.
Phytecs educates consumers about the critical importance of healthy endocannabinoid function. Phytecs develops products that makes achieving optimal health and wellbeing much easier.
Phytecs provides evidence-based guidance to government agencies around the globe as they develop regulations to supervise research and development of products targeting the endocannabinoid system.
Phytecs leads the way in providing its strategic partners with the finest materials and formulations for products that leverage our knowledge of the endocannabinoid system.
Director of Global Research, Chair of Scientific Advisory Board
The endocannabinoid system regulates many key physiological processes, perhaps extending to the biochemistry underlying individual personalities.
Phytecs researches and develops products that support balanced endocannabinoid system function in both health and disease. Technical innovation by Phytecs in natural products chemistry, genomics and bioinformatics may help create the next generation of cannabinoid medicines.
The endocannabinoid system (ECS) is an essential regulator of bodily function in its many facets. There is hardly any physiological process that is not affected by it to some degree. It is surprising then to realize that the ECS was totally unknown prior to one generation ago. The name derives from the fact that the bodies of all higher animals harbor natural chemicals within that resemble in many respects the activity of tetrahydrocannabinol (THC), the phyto- (plant) cannabinoid that is the main psychoactive component of Cannabis sativa, sometimes derisively labeled as marijuana.